Mulmit

KALA BIO, Inc.KALA BIO, Inc.

KALA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-39,161,000-26,980,000-3.31
2024-12-310-40,983,000-38,511,000-10.15
2023-12-310-39,663,000-42,199,000-17.35
2022-12-313,892,000-81,706,000-44,822,000-29.48
2021-12-3111,240,000-130,245,000-142,605,000-108.32

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2025-12-18Lazar David E.Chief Executive Officer368,614
2025-11-24Lazar David E.Chief Executive Officer900,000
2025-10-23Reumuth MaryCHIEF FINANCIAL OFFICER967
2025-10-23Iwicki Mark T154,894
2025-10-22Kharabi DariusCHIEF BUSINESS OFFICER20,806
2025-10-22Reumuth MaryCHIEF FINANCIAL OFFICER32,230
2025-10-22Bazemore Todd47,768
2025-10-22Brazzell Romulus KSEE REMARKS46,748
2025-10-01BAKER BROS. ADVISORS LPFormer 10% owner50,640
2025-10-01BAKER BROS. ADVISORS LPFormer 10% owner462,967
2025-09-30BAKER BROS. ADVISORS LPFormer 10% owner21,376
2025-09-30BAKER BROS. ADVISORS LPFormer 10% owner195,425

8-K events

FiledItems
2026-09-10Entry into a material agreement · Financial statements and exhibits
2026-09-09Shareholder director nominations · Other events
2026-08-28Delisting or listing-standard notice
2026-07-23Other events · Financial statements and exhibits
2026-05-07Material modification to rights of security holders · Amendments to charter or bylaws · Other events · Financial statements and exhibits
2026-03-04Entry into a material agreement · Unregistered sales of equity securities · Regulation FD disclosure
2026-02-20Officer or director change
2026-02-05Officer or director change
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.